|Country:||Switzerland & France|
|Category:||Clinical Stage Company Presentation|
|Room:||Osaka / Samarkand|
|Time:||16:30 – 16:45|
|Speaker:||Jesus MARTIN GARCIA|
GeNeuro is a Phase2 clinical-stage company that develops antibodies to neutralize patient-produced pathogenic proteins that fuel a great number of neurodegenerative and autoimmune diseases.
GeNeuro leverages this approach against diseases such as multiple sclerosis, amyotrophic lateral sclerosis and, more recently, post-COVID neuropsychiatric syndromes.